Leishmania parasite ribosome

The **Leishmania parasite ribosome** is a large ribonucleoprotein complex essential for protein synthesis in the protozoan genus Leishmania, the causative agent of leishmaniasis. Unlike typical eukaryotic ribosomes, the large subunit rRNA of the Leishmania ribosome is uniquely fragmented into several large and small pieces (LSU-α, LSU-β, srRNA1, etc.), a hallmark of kinetoplastid ribosomes[1][7]. Its structure and composition include kinetoplastid-specific protein extensions, which help stabilize these split rRNA fragments and may provide unique interaction sites for small molecules[7]. Functionally, the Leishmania ribosome is responsible for translation of mRNA into proteins and plays a crucial role in stage-specific gene regulation, particularly through dynamic rRNA modifications like pseudouridine, which affect tRNA selectivity and codon usage biases[1][3][5]. These structural differences render it a validated therapeutic target, as drugs such as paromomycin can disrupt parasite protein synthesis by binding selectively to its A-site, a feature not found in mammalian ribosomes. Unique rRNA sequence features also provide the basis for molecular diagnostic tools[2][7]. The ribosome is essential for parasite survival and adaptation, making its components promising targets for selective antiparasitic therapy, though risk of cross-reactivity with host ribosomes and evolving resistance are important considerations[7][8].

Other names

Leishmania ribosomeLeishmania major ribosomeLeishmania donovani ribosomekinetoplastid ribosome

Inhibition of protein synthesis by binding to the ribosomal A-site, causing translational errors and premature termination[7][8] - Modulation of ribosome function via rRNA modification (e.g., pseudouridine alteration), affecting tRNA selection and translation fidelity[1][3][5]